Organogenesis (NASDAQ:ORGO) Issues Quarterly Earnings Results

Organogenesis (NASDAQ:ORGO) issued its earnings results on Tuesday. The company reported $0.09 EPS for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.11, Zacks reports. Organogenesis had a negative net margin of 1.62% and a negative return on equity of 2.69%. The business had revenue of $115.18 million during the quarter, compared to analysts’ expectations of $109.59 million. During the same period in the prior year, the business earned $0.02 earnings per share. Organogenesis updated its FY 2024 guidance to EPS.

Organogenesis Trading Down 3.7 %

ORGO traded down $0.15 on Friday, hitting $3.86. The company had a trading volume of 226,567 shares, compared to its average volume of 823,099. Organogenesis has a 1 year low of $2.16 and a 1 year high of $4.70. The firm has a market cap of $511.76 million, a P/E ratio of -63.50 and a beta of 1.60. The company’s fifty day moving average price is $2.97 and its 200 day moving average price is $2.81. The company has a current ratio of 3.09, a quick ratio of 2.42 and a debt-to-equity ratio of 0.21.

Organogenesis Company Profile

Organogenesis Holdings Inc, a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane in which viable cells, growth factors/cytokines, and ECM proteins in the native tissue are preserved; Novachor, a chorion membrane in which viable cells, growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, cytokines, and growth factors; NuShield, dehydrated placental tissue covering amnion and chorion membranes for spongy/intermediate layer intact; and PuraPly AM, an antimicrobial barrier that enables conformability and fluid drainage.